staurosporine has been researched along with nociceptin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X | 1 |
Armstead, WM | 1 |
2 other study(ies) available for staurosporine and nociceptin
Article | Year |
---|---|
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship | 2008 |
NOC/oFQ PKC-dependent superoxide generation contributes to hypoxic-ischemic impairment of NMDA cerebrovasodilation.
Topics: Alkaloids; Animals; Animals, Newborn; Anions; Benzophenanthridines; Cerebral Arteries; Cerebrovascular Circulation; Enzyme Activation; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Female; Free Radicals; Hypoxia-Ischemia, Brain; Indicators and Reagents; Male; N-Methylaspartate; Nitroblue Tetrazolium; Nociceptin; Opioid Peptides; Peptide Fragments; Phenanthridines; Pia Mater; Protein Kinase C; Staurosporine; Superoxide Dismutase; Superoxides; Swine; Vasodilation; Vasodilator Agents | 2000 |